Meet the Experts

Transforming Patient Access Journey for Rare Disease Asset

Enhancing Communication and Support to Boost Patient Outcomes

Introduction

Our client faced lower-than-expected patient adherence for their pulmonary arterial hypertension (PAH) treatment. They needed to identify access barriers and optimize patient and provider engagement to improve treatment adherence.

The Challenge

The client faced challenges with patient adherence due to a complex access journey. By mapping their journey, we identified key barriers and facilitators to patient access that were impacting treatment adherence and overall outcomes.

    Our Solution

    • Leveraged Herspiegel’s patients’ access journey expertise and identified hypotheses of additional barriers and facilitators specific to PAH.
      • Identified potential solutions the client wanted to test to improve patient access and adherence.
    • Formed the basis of primary market research among target patients and their direct and allied healthcare providers.
    • Gained deep insights into how patients navigate the PAH access journey and the factors influencing their progress.
    • Recommended tactics to optimize patient engagement and support through education and specialty pharmacy services.

    Value Delivered

    We simplified patient communications to enhance understanding of the treatment process and available support options. Additionally, we launched a healthcare provider (HCP) educational campaign to improve provider support in addressing the access challenges faced by patients. These efforts improved patient engagement and adherence through clearer communication and more effective provider guidance.

    Herspiegel Patient Adherence

    Optimize your patient access journey and improve adherence

    Meet the Authors

    Let's Talk

    Herspiegel is a leading professional services firm helping biotech start-ups and the world’s largest pharmaceutical companies navigate the path from science to brand performance and change patients’ lives. We are committed to using strategic insights from medical to commercial to market access to solve critical problems.